Genetic risk scores and dementia risk across different ethnic groups in UK Biobank
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Background: Genetic Risk Scores (GRS) for predicting dementia risk have mostly been used in people of European ancestry with limited testing in other ancestry groups. Methods: We conducted a logistic regression with all-cause dementia as the outcome and z-standardised GRS as the exposure across diverse ethnic groups. Findings: There was variation in frequency of APOE alleles across ethnic groups. Per standard deviation (SD) increase in z-GRS including APOE, the odds ratio (OR) for dementia was 1.73 (95%CI 1.69–1.77). Z-GRS excluding APOE also increased dementia risk (OR 1.21 per SD increase, 95% CI 1.18–1.24) and there was no evidence that ethnicity modified this association. Prediction of secondary outcomes was less robust in those not of European ancestry when APOE was excluded from the GRS. Interpretation: z-GRS derived from studies in people of European ancestry can be used to quantify genetic risk in people from more diverse ancestry groups. Urgent work is needed to include people from diverse ancestries in future genetic risk studies to make this field more inclusive.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430 · cited 2×
“It currently costs the global economy $1 trillion annually and these costs are likely to increase as life expectancy increases [1].”
BackgroundSelf-citationRetractedClinical use of current polygenic risk scores may exacerbate health disparities
Martin, A. R., Kanai, M., Kamatani, Y., Okada, Y., Neale, B. M., & Daly, M. J. (2019) · Nature Genetics · doi:10.1038/s41588-019-0379-x · Cited by 2,821
Current clinical use of polygenic scores will risk exacerbating health disparities
Martin, A. R., Kanai, M., Kamatani, Y., Okada, Y., Neale, B. M., & Daly, M. J. (2018) · doi:10.1101/441261 · Cited by 2,813 · cited 1×
“Using GRS from GWAS conducted in European origin samples to predict disease status in diverse ethnic groups in general could be less accurate than predicting phenotypes in those of European origin [13] due to differences in allele frequencies and patterns of linkage disequilibrium, potentially leading to widening heal…”
MethodGenomics is failing on diversity
Popejoy, A. B., & Fullerton, S. M. (2016) · Nature · doi:10.1038/538161a · Cited by 1,924
The Missing Diversity in Human Genetic Studies
Sirugo, G., Williams, S. M., & Tishkoff, S. A. (2019) · Cell · doi:10.1016/j.cell.2019.02.048 · Cited by 1,516
Power and predictive accuracy of polygenic risk scores
Dudbridge, F. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003348 · Cited by 1,509 · cited 1×
“multiplying the genotype dosage of each risk allele for each variant (except APOE SNPs) by its respective weight (log odds ratio (OR) for dementia), and then summing across all variants and dividing by number of variants [30] (see supplementary text for formula) using the—score function in Plink 2.”
MethodHuman Demographic History Impacts Genetic Risk Prediction across Diverse Populations
Martin, A. R., Gignoux, C. R., Walters, R. K., Wojcik, G. L., Neale, B. M., Gravel, S., Daly, M. J., Bustamante, C. D., & Kenny, E. E. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.03.004 · Cited by 1,391
Association of Lifestyle and Genetic Risk With Incidence of Dementia
Lourida, I., Hannon, E., Littlejohns, T. J., Langa, K. M., Hyppönen, E., Kuzma, E., & Llewellyn, D. J. (2019) · JAMA · doi:10.1001/jama.2019.9879 · Cited by 881 · cited 1×
“Assumptions that GRS developed in European origin participants will not be valid for predicting dementia in people from diverse ancestries has meant that people from diverse ancestries have been excluded from investigations of interactions between genetic risk and environmental risk factors [23] and cognitive trajecto…”
BackgroundLittlejohns, T. J., Holliday, J., Gibson, L. M., Garratt, S., Oesingmann, N., Alfaro-Almagro, F., Bell, J. D., Boultwood, C., Collins, R., Conroy, M. C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15948-9 · Cited by 812 · cited 1×
“An automated processing pipeline for brain image analysis and quality control was established for UKB at the University of Oxford’s Wellcome Centre for Integrative Neuroimaging (WIN/FMRIB) [34].”
MethodTang, M.-X. (1998) · JAMA · doi:10.1001/jama.279.10.751 · Cited by 771
Research works printed but not linked: 33
- L. A. Farrer, 1997, Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis, Jama, 278, 1349, 10.1001/jama.1997.03550160069041 · DOI · Paper page
- M. W. Logue, 2019, Use of an Alzheimer’s disease polygenic risk score to identify mild cognitive impairment in adults in their 50s, Molecular psychiatry, 24, 421, 10.1038/s41380-018-0030-8 · DOI · Paper page
- A. V. Khera, 2018, Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations, Nature genetics, 50, 1219, 10.1038/s41588-018-0183-z · DOI · Paper page
- U. N., 2017, World Population Prospects: the 2017 revision
- S. A. Bien, 2019, The future of genomic studies must be globally representative: perspectives from PAGE, Annual review of genomics and human genetics, 20, 181, 10.1146/annurev-genom-091416-035517 · DOI · Paper page
- J. C. Lambert, 2013, Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease, Nature genetics, 45, 1452, 10.1038/ng.2802 · DOI · Paper page
- M. R. Sabuncu, 2012, The association between a polygenic Alzheimer score and cortical thickness in clinically normal subjects, Cerebral cortex, 22, 2653, 10.1093/cercor/bhr348 · DOI · Paper page
- M. K. Lupton, 2016, The effect of increased genetic risk for Alzheimer’s disease on hippocampal and amygdala volume, Neurobiology of aging, 40, 68, 10.1016/j.neurobiolaging.2015.12.023 · DOI · Paper page
- K. B. Walhovd, 2020, Genetic risk for Alzheimer disease predicts hippocampal volume through the human lifespan, Neurology Genetics, 6, 10.1212/NXG.0000000000000506 · DOI
- M. W. Weiner, 2017, Recent publications from the Alzheimer’s Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials, Alzheimer’s & Dementia, 13, e1, 10.1016/j.jalz.2016.11.007 · DOI · Paper page
- X. Zhou, 2020, Genetic and polygenic risk score analysis for Alzheimer’s disease in the Chinese population, Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 12, e12074
- J. R. Marden, 2014, Validation of a polygenic risk score for dementia in black and white individuals, Brain and behavior, 4, 687, 10.1002/brb3.248 · DOI · Paper page
- J. A. Smith, 2020, Association Between Episodic Memory and Genetic Risk Factors for Alzheimer’s Disease in South Asians from the Longitudinal Aging Study in India–Diagnostic Assessment of Dementia (LASI‐DAD), Journal of the American Geriatrics Society, 68, S45, 10.1111/jgs.16735 · DOI
- M. Riaz, 2021, Effect of APOE and a polygenic risk score on incident dementia and cognitive decline in a healthy older population, Aging cell, 20, e13384, 10.1111/acel.13384 · DOI
- C. Sudlow, 2015, UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age, Plos med, 12, e1001779, 10.1371/journal.pmed.1001779 · DOI · Paper page
- C. Bycroft, 2018, The UK Biobank resource with deep phenotyping and genomic data, Nature, 562, 203, 10.1038/s41586-018-0579-z · DOI · Paper page
- E. Thompson, 1975, The estimation of pairwise relationships, Annals of human genetics, 39, 173, 10.1111/j.1469-1809.1975.tb00120.x · DOI · Paper page
- A. M. Kulminski, 2020, Genetic and regulatory architecture of Alzheimer’s disease in the APOE region, Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 12, e12008
- S. Purcell, 2007, PLINK: a tool set for whole-genome association and population-based linkage analyses, The American journal of human genetics, 81, 559, 10.1086/519795 · DOI · Paper page
- K. Bush, 2018, Definitions of Dementia and the Major Diagnostic Pathologies, UK Biobank Phase 1 Outcomes Adjudication, UK Biobank
- T. Wilkinson, 2019, Identifying dementia outcomes in UK Biobank: a validation study of primary care, hospital admissions and mortality data, European journal of epidemiology, 34, 557, 10.1007/s10654-019-00499-1 · DOI · Paper page
- F. Alfaro-Almagro, 2018, Image processing and Quality Control for the first 10,000 brain imaging datasets from UK Biobank, Neuroimage, 166, 400, 10.1016/j.neuroimage.2017.10.034 · DOI · Paper page
- B. Fischl, 2002, Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain, Neuron, 33, 341, 10.1016/S0896-6273(02)00569-X · DOI · Paper page
- G. P. Consortium, 2015, A global reference for human genetic variation, Nature, 526, 68, 10.1038/nature15393 · DOI · Paper page
- M. P. Conomos, 2015, Robust inference of population structure for ancestry prediction and correction of stratification in the presence of relatedness, Genetic epidemiology, 39, 276, 10.1002/gepi.21896 · DOI · Paper page
- A.-E. Farmaki, 2020, Type 2 diabetes risks and determinants in 2nd generation migrants and mixed ethnicity people of South Asian and African Caribbean descent in the UK, medRxiv, 2019.12. 13.19014704
- B. O. Osuntokun, 1995, Lack of an association between apolipoprotein E e4 and Alzheimer’s disease in elderly Nigerians, Annals of neurology, 38, 463, 10.1002/ana.410380319 · DOI · Paper page
- N. L. Mukadam, 2019, Ethnic differences in cognition and age in people diagnosed with dementia: a study of electronic health records in two large mental healthcare providers, International Journal of Geriatric Psychiatry, 34, 504, 10.1002/gps.5046 · DOI
- N. M. Mukadam, 2021, Risk factors, ethnicity and dementia: a UK Biobank prospective cohort study of White, South Asian and Black participants, 10.2139/ssrn.3854765 · DOI
- C. Lonjou, 2003, Linkage disequilibrium in human populations, Proceedings of the National Academy of Sciences, 100, 6069, 10.1073/pnas.1031521100 · DOI · Paper page
- N. L. Olson, 2020, Race-and Sex-Based Disparities in Alzheimer’s Disease Clinical Trial Enrollment in the United States and Canada: An Indigenous Perspective, Journal of Alzheimer’s Disease Reports, 1
- S. A. T. D. Consortium, 2017, Multiethnic polygenic risk scores improve risk prediction in diverse populations, Genetic epidemiology, 41, 811, 10.1002/gepi.22083 · DOI · Paper page
- W. Zhao, 2017, Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease, Nature genetics, 49, 1450, 10.1038/ng.3943 · DOI · Paper page
Metadata
- Authors
- Mukadam, N., Giannakopoulou, O., Bass, N., Kuchenbaecker, K., & McQuillin, A.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2022-12-07
- Volume
- 17
- Issue
- 12
- Pages
- e0277378
- ISSN
- 1932-6203
- Cited by
- 14
- References
- 19
- Language
- en
- Funders
- Alzheimer's Society (AS-SF-18b-001)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genetic risk scores and dementia risk across different ethnic groups in UK Biobank. https://app.cochat.ai/papers/10.1371/journal.pone.0277378
- The paper
- Mukadam, N., Giannakopoulou, O., Bass, N., Kuchenbaecker, K., & McQuillin, A. (2022). Genetic risk scores and dementia risk across different ethnic groups in UK Biobank. PLOS ONE. https://doi.org/10.1371/journal.pone.0277378
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.